The company trades pharmaceutical products in the field of integrated therapies for rare diseases and intensive care (critical care). It is a 100% subsidiary of AOP Orphan Pharmaceuticals GmbH, Vienna, and is responsible for distribution in Germany. In fiscal year 2023 AOP Orphan Pharmaceuticals Germany generated revenue of EUR 58,195,076.45 and a net profit of EUR 1,288,307.24. At the end of December 2023 the company employed an average of 60 persons.
Großhandel mit pharmazeutischen Erzeugnissen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) München Local Court, HRB 241185 (as of 2 November 2026)
| Name | Type | City |
|---|---|---|
| Georg Fischer | Geschäftsführer(in) | Wien |
| Michael Lange | Geschäftsführer(in) | Lahnau |
| Bernhard Nachbaur | Geschäftsführer(in) | Wien |
Source: German Commercial Register (Handelsregister) München Local Court, HRB 241185 (as of 2 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 16.12.2021 | Company Name Change | AOP Orphan Pharmaceuticals Germany GmbH |
| 16.12.2021 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 30.10.2018 | Business Address Change | Fraunhoferstraße 11, 85737 Ismaning |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 25.05.2018 | Share Capital Set | — | 25.000 € |
| Date | Contract | Value |
|---|---|---|
| 2.3.2026 | Supplier · PBMG eG | — |
Source: German Commercial Register (Handelsregister) München Local Court, HRB 241185 (as of 2 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €84,068,888 | €2,130,128 | €36,586,252 | 59 |
| 2023 | €58,195,076 | €1,288,307 | €18,192,970 | 54 |
| 2022 | €36,090,757 | €568,558 | €13,080,206 | 45 |
| 2021 | €13,087,895 | €328,635 | €9,860,756 | 20 |
| 2020 | — | €175,478 | €4,149,296 | 16 |
| 2019 | — | €90,116 | €3,590,947 | — |
| 2018 | — | -€563,776 | €571,572 | — |
Sign in to download data
Source: German Commercial Register (Handelsregister) München Local Court, HRB 241185 (as of 2 November 2026)
5N Plus Lübeck GmbH
Lübeck · Herstellung von sonstigen anorganischen Grundstoffen und Chemikalien
Home Therapie Management GmbH
Ahrensburg · Großhandel mit medizinischen und orthopädischen Artikeln, Dental- und Laborbedarf
Instron GmbH
Darmstadt · Großhandel mit medizinischen und orthopädischen Artikeln, Dental- und Laborbedarf
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €8,481,554 | 12.3% |
| Material Costs | €60,434,436 | 87.7% |
| Depreciation | €24,647 | 0.0% |
